Multicellular tumor spheroids: an underestimated tool is catching up again

F Hirschhaeuser, H Menne, C Dittfeld, J West… - Journal of …, 2010 - Elsevier
The present article highlights the rationale, potential and flexibility of tumor spheroid mono-
and cocultures for implementation into state of the art anti-cancer therapy test platforms …

Affinity and avidity in antibody-based tumor targeting

SI Rudnick, GP Adams - Cancer Biotherapy and …, 2009 - liebertpub.com
Summation Many factors contribute to successful tumor targeting by antibodies. Besides
properties of the tumor tissue and general antibody pharmacology, a relationship exists …

Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages

K Movahedi, S Schoonooghe, D Laoui, I Houbracken… - Cancer research, 2012 - AACR
Tumor-associated macrophages (TAM) are an important component of the tumor stroma and
exert several tumor-promoting activities. Strongly pro-angiogenic TAMs that reside in …

Immuno-PET: a navigator in monoclonal antibody development and applications

GAMS Van Dongen, GWM Visser… - The …, 2007 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Discuss the
technical advances that have led to recent rapid developments in monoclonal antibody …

Monocytes and macrophages in cancer: development and functions

DM Richards, J Hettinger, M Feuerer - Cancer Microenvironment, 2013 - Springer
Monocytes and tumor-associated macrophages are part of the myeloid family, a group of
hematopoietic derived cells. Monocytes are direct precursors of hematopoietic stem cell …

Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies

M Suzuki, C Kato, A Kato - Journal of toxicologic pathology, 2015 - jstage.jst.go.jp
Antibodies can swiftly provide therapeutics to target disease-related molecules discovered
in genomic research. Antibody engineering techniques have been actively developed and …

Strategies targeting tumor immune and stromal microenvironment and their clinical relevance

M Hu, L Huang - Advanced Drug Delivery Reviews, 2022 - Elsevier
The critical role of tumor microenvironment (TME) in tumor initiation and development has
been well-recognized after more than a century of studies. Numerous therapeutic …

Monoclonal antibodies as neurological therapeutics

P Gklinos, M Papadopoulou, V Stanulovic… - Pharmaceuticals, 2021 - mdpi.com
Over the last 30 years the role of monoclonal antibodies in therapeutics has increased
enormously, revolutionizing treatment in most medical specialties, including neurology …

Anti-GD2 antibody therapy for GD2-expressing tumors

F Navid, VM Santana… - Current cancer drug targets, 2010 - ingentaconnect.com
In the development of novel immune therapies for high-risk cancers, one goal is to find tumor
targets that are not widely shared by normal cells. One such target is the surface …

[HTML][HTML] Nanotechnology in retinal drug delivery

S Jiang, YL Franco, Y Zhou, J Chen - International journal of …, 2018 - ncbi.nlm.nih.gov
Retinal diseases, including age-related macular degeneration (AMD) and diabetic
retinopathy (DR) are the leading causes of blindness in adults over the age of 50 years in …